Investigation Of Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Single Doses Of Vupanorsen In Japanese Healthy Adult Participants With Elevated Triglycerides
Clinical trial NCT04459767 · COMPLETED
Trial details
- NCT number
- NCT04459767
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-06
- Primary completion
- 2020-12-15
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.